title: [Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test].
abstract: BACKGROUND
  Alpha2Macroglobulin (A2M) measure showed a revival since it was introduced into FibroTest-ActiTest-Fibro (FT-AT-Fibro) algorithm. More often than not, this assay is performed in immunonephelemetry. Progresses in the comprehension of fibrosis dynamics and better treatment efficacy follow-up will increase FT-AT-Fibro prescriptions. Despite efforts to standardize methods of enzymatic activity measure and proteins measure, we still observe important interlaboratory and intersystem variability.
  
  
  OBJECTIVE
  The primary aim of the study is to validate immunoturbidimetric measure of A2M on Modular P and Cobas Integra analysers (Roche Diagnostics) in utility channel using DakoCytomation reagents in order to extend the analytical system range allowed to measure A2M. The secondary aim of the study is to verify transferability of the six FT-AT composants (A2M, haptoglobin, apolipoprotein A1, total bilirubin, GGT and ALT) to Roche Diagnostics equipment by comparing with results measured on the reference system.
  
  
  RESULTS
  A2M measures (n = 146) showed linearity, repetitiveness and were reproducible. Readjustments to adapt A2M measures were required. A corrector factor of 0.84 for Modular P and of 0.87 for Cobas Integra was introduced in order to readjust the immunoturbidimetric method to the immunonephelemetric method. The rationale of proposed corrector factors is based on the use of Dade Behring and DakoCytomation reagents (antisera and calibrant). Biologist vigilance is required to point out modifications or variations in reagents that could be done by the company. The six parameters results transferability from the reference system to Roche Diagnostics was demonstrated by statistic analysis. FT-AT showed excellent correlations to the reference system for Modular P and Cobas Integra analysers. In this study no difference more than 0.11 was recorded and only few subjects had differences between 0.05 and 0.10. Therefore this very low inter-analysers variability has no significant clinical impact.
  
  
  CONCLUSIONS
  This study showed that the analytical system made of Modular P, Cobas Integra, Roche Diagnostics and DakoCytomation reagents can be used for FibroTest-ActiTest-Fibro parameters assessment. Their statistical and clinical variability were acceptable compared to the reference system.
authors.affiliation: Fédération de biochimie, hôpital de la Salpêtrière, Paris. annie.piton@noos.fr
authors.forename: A
authors.initials: A
authors.lastname: Piton
authors.forename: D
authors.initials: D
authors.lastname: Messous
authors.forename: F
authors.initials: F
authors.lastname: Imbert-Bismut
authors.forename: J
authors.initials: J
authors.lastname: Bergès
authors.forename: M
authors.initials: M
authors.lastname: Munteanu
authors.forename: T
authors.initials: T
authors.lastname: Poynard
authors.forename: B
authors.initials: B
authors.lastname: Hainque
mesh_terms: D001331:Automation / Q000379:methods; D019963:Clinical Chemistry Tests; D006801:Humans; D007118:Immunoassay / Q000379:methods; D009391:Nephelometry and Turbidimetry / Q000379:methods; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D000511:alpha-Macroglobulins / Q000032:analysis*
chemical_list: D000511:alpha-Macroglobulins